Business Wire

EKOS Corporation Supports the Dutch Randomized Trial Comparing Standard Catheter Directed Thrombolysis vs. Ultrasound Accelerated Thrombolysis for Thrombo-Embolic Infra ...

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation announced today that EKOS and their Netherlands distributor, AngioCare BV, are supporting a Dutch multicentre randomized trial (DUET) designed to ...
FiercePharma

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions EKOS Corporation, a privately ...
TCTMD

EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism

BOTHELL, Wash.-- EKOS Corporation announced today the EKOS EkoSonic® Endovascular System is the first endovascular device approved for the treatment of pulmonary embolism (PE). The EkoSonic® System, ...
Healio

Catheter-directed thrombolysis for PE confers less bleeding vs. mechanical thrombectomy

Please provide your email address to receive an email when new articles are posted on . Catheter-directed thrombolysis was linked to less major bleeding than mechanical thrombectomy in patients with ...
Healio

IVUS-assisted catheter-directed thrombolysis did not enhance thrombus resolution

The addition of IVUS to a fixed-dose catheter thrombolysis regimen failed to facilitate thrombus resolution in patients with acute iliofemoral deep vein thrombosis in the BERNUTIFUL trial. The ...
HeraldNet

Ekos ready to go global

BOTHELL – Ekos Corp., which has spent more than a decade inventing ultrasound-enhanced catheters that can quickly break up blood clots, is ready to sell the device to doctors around the world. The ...
seattlepi.com

Device helps doctors dissolve blood clots

Ekos co-founder Doug Hansmann spent the past nine years developing an ultrasound catheter to help doctors quickly dissolve blood clots in the legs, arms and brain. Now after several fits and starts -- ...
London South East

BTG Receives FDA 510(k) Clearance for EKOS CU 4.0

BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0 London, UK, 27 February 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today announced U.S. Food and Drug ...
seattlepi.com

Treatment speeds drugs to blood clots

For years, the standard treatment for patients with blood clots in veins deep in a limb has been blood thinners that stop the clots from getting bigger. Last month, though, the American College of ...
FierceBiotech

Acquisition of EKOS

BTG plc (BTG or the Company), the specialist healthcare company, is pleased to announce that it has entered into an agreement to buy EKOS Corporation (EKOS) a fast growing and profitable ...
Business Wire

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multi-center ...